ArcticZymes enters RNA therapeutics market with two new enzymes targeting manufacturing and analytical efficiency
Oct 27, 2026
ArcticZymes today announced the early-access launch of RiboClean™ dsDNase and RiboCleave™ 1, its first enzymes developed specifically for RNA therapeutics manufacturing and analysis. The launch coincides with the opening of the 33rd ESGCT Annual Congress at the Congress Centre Hamburg, Germany (27–30 October 2026).